AmSurg-Envision merger closer to final stages as Hart-Scott-Rodino waiting period expires; Surgery Partners Q2 same-facility revenue jumps 14.9% & more — 5 key updates on ASC companies

Here are five updates on ASC companies from the past week.

The Envision Healthcare/AmSurg merger's wait period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 has expired. The wait period pertains to the Federal Trade Commission's review of the proposed merger between the two parties. AmSurg and Envision separately received a request for information from the antitrust division of the State of Florida Attorney General's office. Both organizations are cooperating with the request.

Surgery Partners' same-facility revenues totaled $279.7 million during the second quarter, up 14.9 percent from $243.5 million during the same period in 2015.

Tenet Healthcare shares increased 2.58 percent on Sept. 7. Tenet has a 52-week high of $49.06 and 52-week low of $21.39.

Nobilis Health's total cash was $18.8 million and accounts receivable was $77.6 million during the second quarter.

During the week of Sept. 6 to Sept. 9, Hospital Corporation of America shares fell 0.7 percent, hitting $75.94 per share.

If you have a question, issue or note to suggest on an ASC management and development company please contact Mary Rechtoris at

More articles on surgery centers:
Yearlong CON battle over Green Mountain Surgical Center continues — 5 things to know
8 hospitals, health systems opening or planning ASCs — August 2016
AmSurg-Envision merger closer to final stages as Hart-Scott-Rodino waiting period expires: 5 things to know

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Webinars

Featured Whitepapers

Featured Podcast